Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (441-450 of 612) with videos related to

Pageof 62
Sort By:
Pediatric Blood & Cancer|September 23, 2010
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growthNisha C Kakodkar, Radhika Peddinti, Morris Kletzel, et al.
Journal of the National Cancer Institute|March 5, 1997
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group studyL C Bowman, R P Castleberry, A Cantor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial HospitalAndrew D Campbell, Susan L Cohn, Marleta Reynolds, et al.
Cancer Research|December 25, 2002
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesisAlexandre Chlenski, Shuqing Liu, Susan E Crawford, et al.
Cancer Research|March 3, 2006
The MYCN enigma: significance of MYCN expression in neuroblastomaXao X Tang, Huaqing Zhao, Bing Kung, et al.
Pediatric Blood & Cancer|September 17, 2013
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group projectYaël P Mossé, Rebecca J Deyell, Frank Berthold, et al.
Progress in Clinical and Biological Research|January 1, 1994
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplificationJ M Cheng, J L Hiemstra, S S Schneider, et al.
Cellular Immunology|March 1, 1986
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual menB S Dobozin, F N Judson, D L Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.
Journal of the National Cancer Institute|December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survivalEric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Pageof 62

Showing results (441-450 of 612) with videos related to

Sort By:
Pageof 62
Pediatric Blood & Cancer|September 23, 2010
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growthNisha C Kakodkar, Radhika Peddinti, Morris Kletzel, et al.
Journal of the National Cancer Institute|March 5, 1997
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group studyL C Bowman, R P Castleberry, A Cantor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial HospitalAndrew D Campbell, Susan L Cohn, Marleta Reynolds, et al.
Cancer Research|December 25, 2002
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesisAlexandre Chlenski, Shuqing Liu, Susan E Crawford, et al.
Cancer Research|March 3, 2006
The MYCN enigma: significance of MYCN expression in neuroblastomaXao X Tang, Huaqing Zhao, Bing Kung, et al.
Pediatric Blood & Cancer|September 17, 2013
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group projectYaël P Mossé, Rebecca J Deyell, Frank Berthold, et al.
Progress in Clinical and Biological Research|January 1, 1994
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplificationJ M Cheng, J L Hiemstra, S S Schneider, et al.
Cellular Immunology|March 1, 1986
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual menB S Dobozin, F N Judson, D L Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.
Journal of the National Cancer Institute|December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survivalEric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Pageof 62